A retrospective study to investigate efficacy and safety of brentuximab vedotin in adult patients with relapsed CD30-positive lymphomas.
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2015
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Anaplastic large cell lymphoma; Hodgkin's disease; Lymphoma
- Focus Therapeutic Use
- 05 Dec 2015 New trial record